Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Current Opinion in Cardiology|January 21, 2025
Genetics, manifestations, and management of catecholaminergic polymorphic ventricular tachycardiaShubh Desai, Oliver M Moore, Xander H T WehrensArchives of Toxicology|October 10, 2022
Role of Ca<sup>2+</sup> in healthy and pathologic cardiac function: from normal excitation-contraction coupling to mutations that cause inherited arrhythmiaJoshua A Keefe, Oliver M Moore, Kevin S Ho, et al.Cells|July 6, 2023
Genome Editing and Cardiac ArrhythmiasOliver M Moore, Kevin S Ho, Juwan S Copeland, et al.Current Protocols|February 19, 2024
In Vivo Cardiac Electrophysiology in Mice: Determination of Atrial and Ventricular Arrhythmic SubstratesJose Alberto Navarro-Garcia, Florian Bruns, Oliver M Moore, et al.Heart Rhythm|October 4, 2024
Structure-activity optimization of ryanodine receptor modulators for the treatment of catecholaminergic polymorphic ventricular tachycardiaOliver M Moore, Martha Sibrian-Vazquez, Jose Alberto Navarro-Garcia, et al.The Journal of Cardiovascular Aging|March 11, 2024
Long-term efficacy and safety of cardiac genome editing for catecholaminergic polymorphic ventricular tachycardiaOliver M Moore, Yuriana Aguilar-Sanchez, Satadru K Lahiri, et al.The Journal of Clinical Investigation|August 15, 2023
Chronic kidney disease promotes atrial fibrillation via inflammasome pathway activationJia Song, Jose Alberto Navarro-Garcia, Jiao Wu, et al.Circulation|July 21, 2020
Loss of SPEG Inhibitory Phosphorylation of Ryanodine Receptor Type-2 Promotes Atrial FibrillationHannah M Campbell, Ann P Quick, Issam Abu-Taha, et al.Journal of Molecular and Cellular Cardiology|July 3, 2024
Targeting calpain-2-mediated junctophilin-2 cleavage delays heart failure progression following myocardial infarctionSatadru K Lahiri, Jiao Lu, Yuriana Aguilar-Sanchez, et al.Circulation. Arrhythmia and Electrophysiology|September 26, 2025
Intellectual and Neurodevelopmental Delays in Pediatric Catecholaminergic Polymorphic Ventricular Tachycardia: Distinct Characteristics and a More Malignant Neurocardiac PhenotypeChristina Y Miyake, Dania Kallas, Sara B Stephens, et al.Pageof 1